SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech - Quaterly Results

08 Aug 2023 Evaluate
The Revenue for the quarter ended  June 2023 of Rs. 405.03 millions grew by 22.41 % from Rs. 330.88 millions.A humble growth in net profit of 23.20% reported in the quarter ended June 2023 to Rs. 44.18  millions from Rs. 35.86 millions.Operating profit surged to 77.90 millions from the corresponding previous quarter of 66.19 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 405.03 330.88 22.41 405.03 330.88 22.41 1378.84 1154.45 19.44
Other Income 3.79 9.62 -60.60 3.79 9.62 -60.60 24.62 17.20 43.14
PBIDT 77.90 66.19 17.69 77.90 66.19 17.69 266.09 252.74 5.28
Interest 9.56 7.67 24.64 9.56 7.67 24.64 29.23 14.01 108.64
PBDT 68.34 58.52 16.78 68.34 58.52 16.78 236.86 238.73 -0.78
Depreciation 16.80 15.27 10.02 16.80 15.27 10.02 63.54 57.71 10.10
PBT 51.54 43.25 19.17 51.54 43.25 19.17 173.32 181.02 -4.25
TAX 7.36 7.39 -0.41 7.36 7.39 -0.41 23.31 31.97 -27.09
Deferred Tax -5.09 -2.39 112.97 -5.09 -2.39 112.97 -13.69 -7.80 75.51
PAT 44.18 35.86 23.20 44.18 35.86 23.20 150.01 149.05 0.64
Equity 126.51 122.17 3.55 126.51 122.17 3.55 126.51 122.17 3.55
PBIDTM(%) 19.23 20.00 -3.85 19.23 20.00 -3.85 19.30 21.89 -11.85

Medicamen Biotech Share Price

256.40 -0.70 (-0.27%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×